MabVax Therapeutics – “When is a Fully Human Antibody Really Fully Human”

NEW YORK, NY / ACCESSWIRE / July 16, 2015 / MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) today published a new blog post on The Chairman’s Blog, written by the Company’s Chief Executive Officer, David Hansen. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his new post, Mr. Hansen highlights the unique nature of MabVax’s antibody discovery platform, commenting, “[MabVax is] the only company in the world that really does find fully human antibodies in the full sense of the term.” Hansen writes that the Company’s highly directive discovery process, along with the antibodies’ low risk of serious side effects, opens MabVax up to a myriad of partnership opportunities in the future. Read the full blog post from Mr. Hansen on TheChairmansBlog.com (http://www.thechairmansblog.com/mabvax-therapeutics/david-hansen/when-is-a-fully-human-antibody-really-fully-human/).

About MabVax Therapeutics

MabVax Therapeutics Holdings, Inc. is a clinical stage oncology drug development company focused on the development of human antibody-based products and vaccines to address unmet medical needs in the treatment of cancer. MabVax has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers with the Company’s proprietary vaccines. MabVax is preparing to enter two Phase 1 clinical trials of HuMab 5B1 – one for the diagnosis, and the other for the treatment, of metastatic pancreatic cancer in late 2015. MabVax has the exclusive license to therapeutic vaccines from Memorial Sloan Kettering Cancer Center. MabVax has two cancer vaccines targeting recurrent sarcoma and ovarian cancer in proof of concept Phase II multi-center clinical trials, and a vaccine targeting neuroblastoma that will be ready for Phase II clinical trial later this year. Additional information about the Company is available at www.mabvax.com.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 430620